Latest Breaking News On - நேஹா அரோரா - Page 17 : comparemela.com

By Neha Arora and Krishna N. Das NEW DELHI (Reuters) - India s output of COVID-19 shots for August-December is likely to be lower than the government s public estimate, according to internal projections shared with Reuters by two sources. Lower-than-expected production could delay India s plans to vaccinate all its adults this year, amid fears the country will face another surge of coronavirus infections in the winter. India s ongoing second wave, the world s worst since the pandemic began, has overwhelmed its health system. The government last week publicly estimated 1.46 billion doses of its three approved shots - AstraZeneca, Sputnik V and Covaxin - would be made between August and December. Production of the AstraZeneca vaccine, of which the Serum Institute of India (SII) is the biggest maker in the world, is expected to reach 100 million to 110 million doses a month from July and stay at that level for the foreseeable future, a source with knowledge of the matter said. That would

United statesPhilippa fletcherKrishnan dasNarendra modiNeha aroraMinistry of healthSerum institute of indiaSerum institutePrime minister narendra modiFamily welfareCovaxin maker bharat biotechCompany informationஒன்றுபட்டது மாநிலங்களில்பிலிப்பா பிளெட்சர்கிருஷ்ணன் தாஸ்நரேந்திர மோடி